Fortrea reported a mixed financial performance for Q4 FY2025, with revenues slightly declining year-over-year but a strong book-to-bill ratio indicating future demand. The company achieved its full-year revenue and adjusted EBITDA targets, exceeding cost-saving goals, but faced a significant GAAP net loss due to goodwill impairment charges from earlier in the year. Management highlighted positive client feedback and a strengthened balance sheet, positioning the company for a return to growth.
Full-year cost savings exceeded previously communicated targets.
positiveFourth-quarter book-to-bill ratio of 1.14x, resulting in 1.02x book-to-bill for the trailing 12 months.
positiveFull year adjusted net income increased to $40.4 million from $30.1 million in the prior year.
positiveStrengthened balance sheet through disciplined capital allocation and continued debt paydown.
positiveFourth quarter revenues declined to $660.5 million from $697.0 million in the prior year.
negativeFull year GAAP net loss was $(986.2) million, including a $(797.9) million goodwill impairment charge.
negativeFull year adjusted EBITDA decreased to $189.9 million from $202.5 million in the prior year.
negativeFull year GAAP net loss of $(10.81) per diluted share, compared to $(3.67) in the prior year.
negativeFourth quarter adjusted net income decreased to $9.2 million ($0.09 per diluted share) from $16.6 million ($0.18 per diluted share) in the prior year.
negativeFull year 2026 revenue guidance of $2,550 million to $2,650 million is below 2025 full-year revenue of $2,723.4 million.
negativeMargin expansion indicates improving profitability and operational efficiency. Measured in basis points (bps): 100 bps = 1.0%.
Forward-looking guidance is subject to change and does not constitute a guarantee. Actual results may differ materially from these estimates.
Special items are non-recurring events that may distort period-over-period comparisons. Analysts typically adjust for these when calculating normalized earnings.
We finished 2025 with solid results for the fourth quarter, as the Fortrea team’s shared commitment to commercial, operational and financial excellence becomes embedded in our way of working.
After a challenging first half of the year, we delivered a second half of strong book-to-bills.
Our large pharma and biotech clients are giving our project teams very positive feedback across the board, as we work to meet and exceed their expectations every day.
Commentary excerpts from earnings call transcripts provide management's perspective on performance, strategy, and outlook. Always review full transcripts for complete context.
Operational metrics provide insight into business drivers and customer engagement beyond traditional financial measures.